Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigious | ||
Readability |
H.S. freshman Avg
|
New words:
abstained, acquisition, appointment, Army, assemble, assembling, assembly, Assuming, Audit, Beacon, Bioscience, blocker, Brentwood, building, Burnham, Carolina, clarification, Committee, complementary, consummate, consummated, consummation, CPA, DAT, Dell, disposal, disrupted, diverse, diversion, Dopamine, eighty, estate, exit, firm, floor, FLUOROTEC, formula, goodwill, Hill, IIb, imputed, Incentive, incurrence, intangible, jeopardize, Landlord, left, LLP, located, Mitchell, multiple, North, nPT, overpaid, percentage, PET, pipeline, predetermined, prescribed, proportionate, PT, quantitation, Raleigh, ratify, real, registered, relocated, relocation, rentable, rental, reproducible, requisite, restructuring, selection, subtenant, technical, Transporter, typically, underway, uniform, unregistered, vision, waiver
Removed:
accelerate, constrained, scan, scanning
Filing tables
Filing exhibits
- 10-Q Quarterly report
- 10.1 Amendment of Lease
- 10.2 Sublease Between Boston Life Sciences, Inc. and Small Army, Inc.
- 10.3 Sublease Between Boston Life Sciences,inc. and Dell Mitchell Architects, Inc.
- 10.4 Severance and Settlement Agreement and Release
- 10.5 Common Stock Purchase Agreement
- 10.6 Amendment No. 1 to Amended and Restated Registrations Rights Agreement
- 10.7 Boston Life Sciences License Amendment January 2004 Hu 1382
- 10.8 Boston Life Sciences License Amendment January 2004 Hu 1194
- 31.1 Section 302 CEO Certification
- 31.2 Section 302 CFO Certification
- 32.1 Section 906 CEO Certification
- 32.2 Section 302 CFO Certification
Alseres Pharmaceuticals similar filings
Filing view
External links